Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-20T15:16:45.306Z Has data issue: false hasContentIssue false
  • English
  • Français

Obesity and related medical conditions: a role for functional foods

Published online by Cambridge University Press:  02 January 2007

Wyndham J Boobier ,
Julien S Baker  and
Bruce Davies
Wyndham J Boobier*
Affiliation:
Health and Exercise Science Research Unit, School of Applied SciencesUniversity of Glamorgan, Pontypridd, CF37 1DL, UK
Julien S Baker
Affiliation:
Health and Exercise Science Research Unit, School of Applied SciencesUniversity of Glamorgan, Pontypridd, CF37 1DL, UK
Bruce Davies
Affiliation:
Health and Exercise Science Research Unit, School of Applied SciencesUniversity of Glamorgan, Pontypridd, CF37 1DL, UK
*
*Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the Editor
Information
Public Health Nutrition , Volume 8 , Issue 8 , December 2005 , pp. 1328 - 1329
Copyright
Copyright © The Authors 2005

References

1Keys, A. Coronary heart disease in seven countries. Circulation 1970; 41: 11–211.Google Scholar
2Gotto, AM Jr. High density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. American Heart Journal 2002; 144: S33–S42.CrossRefGoogle ScholarPubMed
3Yudkin, J, Kang, SS, Bruckdorfer, KR. Effects of high dietary sugar. British Medical Journal 1980; 281: 1396.CrossRefGoogle ScholarPubMed
4Jeppesen, J, Hein, HO, Saudicani, P, Gyntelberg, F. High triglycerides/low high-density lipoprotein cholesterol, ischemic electrocardiogram changes, and risk of ischemic heart disease. American Heart Journal 2003; 145: 103–8.CrossRefGoogle ScholarPubMed
5Zieden, B, Kaminskas, A, Kristenson, M, Olsson, AG, Kucinskiene, Z. Long chain polyunsaturated fatty acids may account for higher low-density lipoprotein oxidation susceptibility in Lithuanian compared to Swedish men. Scandinavian Journal of Clinical and Laboratory Investigation 2002; 62: 307–14.CrossRefGoogle ScholarPubMed
6Nisbett, EF, Rossiter, AH, Miller, AR, Thacker, D. Fat is short dough biscuits. Flour Milling and Baking Research Association. 1986; (2): 63–77.Google Scholar
7Davis, MM, Jones, DW. The role of lifestyle management in the overall treatment plan for prevention of management of hypertension. Seminars in Nephrology 2002; 22: 35–43.CrossRefGoogle ScholarPubMed
8Franklin, SS, Khan, SA, Wong, ND, Larson, MG, Levy, D. Is pulse pressure useful in predicting risk factors for coronary heart disease? The Framingham Heart Study. Circulation 1999; 100: 354–60.CrossRefGoogle ScholarPubMed
9Van den Hoogen, PC, Feskens, EJ, Nagelkerke, NJ, Menotti, A, Nissinen, A, Kromhout, D. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. New England Journal of Medicine 2000; 342: 1–8.CrossRefGoogle ScholarPubMed
10He, J, Ogden, LG, Vupputuri, S, Bazzano, L, Loria, C, Whelton, PK. Dietary sodium intake and myocardial infarction. Journal of the American Medical Association 1999; 282: 2027–34.CrossRefGoogle Scholar
11Krauss, RM, Deckelbaum, RJ, Ernst, N, Fisher, E, Howard, BV, Knopp, RH, et al. Dietary guidelines for healthy American adults: a statement for health professionals from the nutrition committee, American Heart Association. Circulation 1996; 94: 1795–800.CrossRefGoogle ScholarPubMed
12Pietinen, P, Rimm, EB, Korhonen, P, Hartman, AM, Willett, WC, Albanes, D, et al. Intake of dietary fibre and risk of coronary heart disease in a cohort of Finnish men. The alpha-Tocopherol Beta-Carotene Prevention Study. Circulation 1996; 94: 2720–7.CrossRefGoogle Scholar
13Rimm, EB, Ascherio, A, Giovannucci, E, Spiegelman, D, Stampfer, MJ, Willett, WC. Vegetable, fruit and cereal fibre intake and risk of coronary heart disease among men. Journal of the American Medical Association 1996; 275: 447–51.CrossRefGoogle ScholarPubMed
14McCully, KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. American Journal of Pathology 1969; 56: 111–28.Google ScholarPubMed
15Klerk, M, Verhoef, P, Verbruggen, B, Schouten, EG, Blom, HJ, Bos, GM, et al. Effect of homocysteine reduction by B vitamin supplementation on marker of clotting activation. Thrombosis and Haemostasis 2002; 88: 230–5.CrossRefGoogle Scholar
16Billion, S, Tribout, B, Cadet, E, Queinnec, C, Rochette, J, Wheatley, P, et al. Hyperhomocysteinemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12. Nephrology, Dialysis, Transplantation 2002; 17: 455–61.CrossRefGoogle ScholarPubMed
17Genest, F Jr. Homocysteine: to screen and treat or wait and see? Canadian Medical Association Journal 2000; 163: 37–8.Google ScholarPubMed
18Hoefler, G, Harnoncourt, F, Pashcke, E, Mirtl, W, Pfeiffer, KH, Kostner, GM. Lipoprotein(a) Lp(a). A risk factor for myocardial infarction. Arteriosclerosis 1988; 8: 394–401.CrossRefGoogle ScholarPubMed
19Sandkamp, M, Funke, H, Schulte, EK, Assman, G. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clinical Chemistry 1990; 36: 20–3.CrossRefGoogle ScholarPubMed
20Rosengren, A, Wilhelmsen, L, Eriksson, E, Risberg, B, Wedel, H. Lipoprotein (a) and coronary heart disease: a prospective case control study in a general population sample of middleaged men. British Medical Journal 1990; 301: 1248–51.CrossRefGoogle Scholar
21Batiste, MC, Schaefer, EJ. Diagnosis and management of lipoprotein abnormalities. Nutrition in Clinical Care 2002; 5: 115–23.CrossRefGoogle ScholarPubMed
22Pieper, JA. Understanding niacin formulations. American Journal of Managed Care 2002; 8: S308–14.Google ScholarPubMed
23Pan, J, Van, JT, Chan, RL, Lin, M, Charles, MA. Extended-release niacin treatment of the atherogenic lipid profile and lipoprotein (a) in diabetes. Metabolism 2002; 52: 1120–7.CrossRefGoogle Scholar